Monotherapy versus combination therapy for sepsis due to multidrugresistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort-authors' response

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 11, 2014, Pages 3167-3168

  Lopez Cortes L E ^a   Rodriguez Bano J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

A. baumannii; Bacteraemia; Infection control; Pneumonia

Indexed keywords

ACINETOBACTER BAUMANNII; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; GRAM NEGATIVE BACTERIUM; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; LETTER; MONOTHERAPY; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; SAMPLE SIZE; SEPSIS; SURVIVAL; ACINETOBACTER INFECTIONS; DRUG EFFECTS; FEMALE; ISOLATION AND PURIFICATION; MALE;

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; SEPSIS;

EID: 84931837096     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku327     Document Type: Letter

References (7)

1. López-Cortés LE, Cisneros JM, Fernández-Cuenca F et al. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort. J Antimicrob Chemother 2014; 69: 3119-26.
2. Karabay O, Batirel A, Balkan II. Comment on: Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort. J Antimicrob Chemother 2014; 69: 3167.
3. Paul M, Carmeli Y, Durante-Mangoni E et al. Combination therapy for carbapenem-resistant Gram-negative bacteria. J Antimicrob Chemother 2014; 69: 2305-9.
4. Tumbarello M, Viale P, Viscoli C et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55: 943-50.
5. Qureshi ZA, Paterson DL, Potoski BA et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56: 2108-13.
6. Durante-Mangoni E, Signoriello G, Andini R et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 2013; 57: 349-58.
7. Aydemir H, Akduman D, Piskin N et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 2013; 141: 1214-22.